- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 14, 2026 | 38.9M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 38.9M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 10.7M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $6.87K |
| Capex | Q1 2026 · Mar 31, 2025 | $61.24K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$1.49M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$3.76M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $21.48M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $25.18M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $119.39M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $121.08M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $3.23M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $5.93M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $3.99M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $6.92M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $35.3M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $44.77M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $131.74M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $136.59M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.12 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.78 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.12 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.78 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $2.93M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $3.6M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$4.52M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$8.33M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$2.65M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$3.93M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $275.11K |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $290.77K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $705.67K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $777.53K |
| Revenue | Q1 2026 · Mar 31, 2026 | $980.78K |
| Revenue | Q1 2026 · Mar 31, 2025 | $1.07M |